Curiteva has filed a notice of an exempt offering of securities to raise $10,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Curiteva is raising $10,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Mike English played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Curiteva
Curiteva is a privately held technology and manufacturing company dedicated to advancing spine surgery and improving clinical outcomes by partnering with providers and suppliers to deliver innovative and intuitive implant systems to the market. Our business is founded on a commitment to building world-class manufacturing, accelerating research and development, maintaining lean operational discipline, and delivering novel technology to meet the evolving needs of our customers and the patients they serve.
To learn more about Curiteva, visit http://www.curiteva.com/
Contact:
Mike English, Chief Executive Officer
256-213-1057
https://www.linkedin.com/in/mike-english-92507312/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.